Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Characteristics of Participants Who Completed Enrollment Study Visit, by Chronic Hepatitis C Virus Status Characteristic | Participants With HCV (n = 58) | Participants Without HCV (n = 58) | P Value: Vitamin D supplement use | 11 (19.0) | 17 (29.3) | .193

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We conducted a cross-sectional study among 58 participants with chronic HCV and 58 participants without HCV.

Source: Abstract.

Interested patients were screened for potential eligibility via self-reported responses.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines

Cross-sectional study · Open Forum Infectious Diseases · 2025

Original publication title

Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines

Erica J Weinstein; Dean M Carbonari; Craig W Newcomb; Jessie Torgersen; Shanae M Smith; Katherine L Brecker; X Sherry Liu; Jay R Kostman; Stacey Trooskin; Rebecca A Hubbard; Joshua F Baker; Babette S Zemel; Mary B Leonard; Vincent Lo Re III

© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Patients with chronic HCV had decreased trabecular volumetric BMD and cortical dimensions and higher TNF-α than individuals without infection, suggesting that HCV-associated inflammation might contribute to bone deficits.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Hepatitis C virus (HCV) infection is associated with reduced bone mineral density (BMD) and increased fracture risk. The structural underpinnings for skeletal fragility with HCV and contributions of inflammatory cytokines remain unknown. We used high-resolution peripheral quantitative computed tomography (HR-pQCT) to compare skeletal parameters by chronic HCV.

Source: Background

Abstract: What methods does the paper describe?

We conducted a cross-sectional study among 58 participants with chronic HCV and 58 participants without HCV. Volumetric BMD and cortical dimensions of the radius and tibia were determined by HR-pQCT; visceral fat area and appendicular lean mass were assessed by whole body dual-energy x-ray absorptiometry; serum levels of tumor necrosis factor α (TNF-α), interleukin 6, and interleukin 18 were measured. Multivariable linear regression was used to estimate group differences in bone measurements and cytokines.

Source: Methods

Abstract: Results

Participants with chronic HCV had lower radius trabecular volumetric BMD (−24.2 mg hydroxyapatite [HA]/cm3) and lower tibia trabecular volumetric BMD (−20.5 mg HA/cm3), cortical area (−20.9 mm2), and cortical thickness (−0.47 mm) than participants without HCV (all P < .05), independent of age, sex, visceral fat area, appendicular lean mass, and smoking. Mean log TNF-α was higher with chronic HCV (+0.1-log pg/mL; P < .001), but no differences in mean log interleukin 6 or interleukin 18 were observed.

Higher log TNF-α was associated with lower radius trabecular volumetric BMD (−99.7 mg HA/cm3), lower tibia cortical volumetric BMD (−91.6 mg HA/cm3), and higher tibia cortical porosity (+1.39%) by HR-pQCT (all P < .05).

Source: Results

Abstract: Conclusions

Patients with chronic HCV had decreased trabecular volumetric BMD and cortical dimensions and higher TNF-α than individuals without infection, suggesting that HCV-associated inflammation might contribute to bone deficits.

Source: Conclusions
Authors’ abstract

Abstract

Background

Hepatitis C virus (HCV) infection is associated with reduced bone mineral density (BMD) and increased fracture risk. The structural underpinnings for skeletal fragility with HCV and contributions of inflammatory cytokines remain unknown. We used high-resolution peripheral quantitative computed tomography (HR-pQCT) to compare skeletal parameters by chronic HCV.

Methods

We conducted a cross-sectional study among 58 participants with chronic HCV and 58 participants without HCV. Volumetric BMD and cortical dimensions of the radius and tibia were determined by HR-pQCT; visceral fat area and appendicular lean mass were assessed by whole body dual-energy x-ray absorptiometry; serum levels of tumor necrosis factor α (TNF-α), interleukin 6, and interleukin 18 were measured. Multivariable linear regression was used to estimate group differences in bone measurements and cytokines.

Results

Participants with chronic HCV had lower radius trabecular volumetric BMD (−24.2 mg hydroxyapatite [HA]/cm3) and lower tibia trabecular volumetric BMD (−20.5 mg HA/cm3), cortical area (−20.9 mm2), and cortical thickness (−0.47 mm) than participants without HCV (all P < .05), independent of age, sex, visceral fat area, appendicular lean mass, and smoking. Mean log TNF-α was higher with chronic HCV (+0.1-log pg/mL; P < .001), but no differences in mean log interleukin 6 or interleukin 18 were observed.

Higher log TNF-α was associated with lower radius trabecular volumetric BMD (−99.7 mg HA/cm3), lower tibia cortical volumetric BMD (−91.6 mg HA/cm3), and higher tibia cortical porosity (+1.39%) by HR-pQCT (all P < .05).

Conclusions

Patients with chronic HCV had decreased trabecular volumetric BMD and cortical dimensions and higher TNF-α than individuals without infection, suggesting that HCV-associated inflammation might contribute to bone deficits.

Publication and source details

Original title: Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines

Erica J Weinstein; Dean M Carbonari; Craig W Newcomb; Jessie Torgersen; Shanae M Smith; Katherine L Brecker; X Sherry Liu; Jay R Kostman; Stacey Trooskin; Rebecca A Hubbard; Joshua F Baker; Babette S Zemel; Mary B Leonard; Vincent Lo Re III

Open Forum Infectious Diseases · 2025

Correspondence: Vincent Lo Re III, MD, MSCE, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, 836 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104-6021 (vincentl@pennmedicine.upenn.edu); Erica J. Weinstein, MD, MSCE, Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 3801 Filbert St, Suite 103, Philadelphia, PA 19104 (erica.weinstein@pennmedicine.upenn.edu).

Potential conflicts of interest. All authors: No reported conflicts.

© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.2025https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. National Institute of Allergy and Infectious Diseases10.13039/100000060 R01 AI136626F32 AI164809 National Center for Advancing Translational Sciences10.13039/100006108 UL1 TR001878 National Institutes of Health10.13039/100000002

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:29:15.984449+00:00

DOI: 10.1093/ofid/ofaf102 · PMC12039487